Regeneron Pharmaceuticals (REGN)
$555.24 9.76 (1.73%)
19:54 EDT REGN Stock Quote Delayed 30 Minutes
Previous Close $555.24
Market Cap 58.83B
PE Ratio 45.00
Volume (Avg. Vol.) 1.98M
Day's Range 544.96 - 567.83
52-Week Range 271.37 - 664.64
Dividend & Yield N/A (N/A)
REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News
- From InvestorPlace
- From the Web
A handful of pharmaceutical stocks have been on fire lately, but I'm writing for a "buy" prescription for five of the best names now.
Regeneron is trialing a cocktail of antibodies that may treat Covid-19 and prevent illness for people routinely exposed.
It may be time to continue selling in May, but not for these all-star earnings stocks to buy. Here's why each stands out from the crowd.
Covid-19 has put the biotech stocks in the spotlight, but treatments for the pandemic are far from the only reason investors should watch this space.
Despite a year-to date drop of -13.9%, the S&P 500 could still be overpriced by 35%. If the S&P 500 is overvalued, component stocks must be.
In times like this, investors are better off focusing on large-cap stocks that offer size, capital and products the economy truly relies on.
Regeneron has solid cash flow and a strong balance sheet. Oh and Regeneron stock is flirting with a major breakout.
With markets in rebound mode, Goldman Sachs thinks these are the 5 stocks to buy to play an economic recovery.
Stocks slipped, but didn't plummet in the stock market today despite a horrendous jobs report that highlight the impact of Covid-19.
April Fool's Day took many long-side traders by surprise. Thursday's big stock charts feature ones that showed resilience while the markets sank.
These biotech stocks are all working on treatments that have the potential to beat the coronavirus. Don't just wait for a cure. Buy them now.
Looking for hot stocks for 2020? These five stocks in particular have steadily outperformed the broader market during the coronavirus crisis.
Matt McCall is confident that, at least in the long term, the stimulus package will inject cash into the economy and help bring new highs.
3 Big Stock Charts for Tuesday: Abbott Laboratories, Johnson & Johnson, and Regeneron Pharmaceuticals
Tuesday's big stock charts feature three companies that are contributing, in their own ways, to the fight against the coronavirus.
While coronavirus fears have killed the stock market this year, these nine best stocks for 2020 have bucked the trend.
These three will undoubtedly become stocks to buy. For right now they're critical stocks to watch as the market attempts to locate a bottom.
The coronavirus is an immediate catalyst for Regeneron stock but it's also too unreliable to provide buyers with lasting confidence.
Gainers: Shiloh Industries (NASDAQ:SHLO) +120%.Kensington Capital Acquisition (KCAC) +63%.India Globalization Capital (NYSEMKT:IGC) +50%.FTS International (NYSEMKT:FTSI) +37%.Garrett Motion (NYSE:GTX) +28%.Ebang International (NASDAQ:EBON) +21%.Applied Genetic Technologies (NASDAQ:AGTC) +16%.Sunlands Technology (NYSE:STG) +16%.Sutro Biopharma (NASDAQ:STRO) +15%.Panhandle Oil and Gas (NYSE:PHX) +13%.Losers: Akebia Therapeutics (NASDAQ:AKBA) -73%.Zuora (NYSE:ZUO) -31%.PagerDuty (NYSE:PD) -28%.Ciena (NYSE:CIEN) -26%.Renren (NYSE:RENN) -24%.SuperCom (NASDAQ:SPCB) -22%.Designer Brands (NYSE:DBI) -19%.Color Star Technology (NASDAQ:HHT) -17%.The Michaels Companies (NASDAQ:MIK) -17%.Grindrod Shipping (NASDAQ:GRIN) -11%.
Navellier RatingsPowered by Portfolio Grader